Chen, Maylee <br/><br/>
Drug-metabolizing enzyme inhibition by ketoconazole does not reduce interindividual variability of CYP3A activity as measured by oral midazolam.  [electronic resource] 

 -  Drug metabolism and disposition: the biological fate of chemicals  Dec 2006 
 - 2079-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0090-9556 
<br/><br/><label>Standard No.: </label>10.1124/dmd.106.011742  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Cross-Over Studies<br/>Cytochrome P-450 CYP3A Inhibitors<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Humans<br/>Ketoconazole--pharmacology<br/>Male<br/>Midazolam--blood<br/>Middle Aged